- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01268423
Early Percutaneous Tracheostomy and Swallowing Dysfunction
January 4, 2011 updated by: University of Chile
Impact of Early Percutaneous Tracheostomy on the Incidence of Swallowing Dysfunction in Critically Ill Patients on Mechanical Ventilation. A Randomized Clinical Trial
The aim of the study is to determine if performing an early tracheostomy (within the first 4 days of endotracheal intubation) in critically ill patients on mechanical ventilation, reduces the incidence of swallowing dysfunction.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The development of initial resuscitation maneuvers, associated with a better knowledge of the physiopathology of critical illnesses and the technological development experienced by critical care medicine, allow us to give vital support to patients for long periods of time.
In this scenario, a considerable proportion of critically ill patients may require translaryngeal intubation and invasive mechanical ventilation.
Patients who require prolonged translaryngeal intubation have a high risk of developing swallowing dysfunction, a condition predisposing to secretions aspiration.
Until now, there has been no demonstration of a causal association between the duration of translaryngeal intubation and development of swallowing dysfunction.
However, all the studies about this topic have been performed on patients submitted to prolonged translaryngeal intubation.
Clinical studies have documented the development of early laryngotracheal lesions after intubation, which might explain post extubation dysfunction of swallowing reflex, probably as consequence of alteration of mechanic and chemo-receptors of the pharyngeal and laryngeal mucosa.
There are no studies evaluating the impact of an early percutaneous tracheostomy on the incidence of swallowing dysfunction in critical care patients.
The investigators have documented a 38% of swallowing dysfunction in our critically ill patients submitted to prolonged mechanical ventilation.
The hypothesis of the study is that performance of an early percutaneous tracheostomy, within the first 4 days of translaryngeal intubation, in critical care patients on mechanical ventilation, reduces the incidence of swallowing dysfunction.
The diagnosis of swallowing dysfunction will be performed by fiberoptic endoscopic evaluation of swallowing (FEES) by a trained otolaryngologist, 3 to 5 days after weaning of mechanical ventilation.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Carlos M Romero, MD
- Phone Number: 0562 - 9788264
- Email: caromero@redclinicauchile.cl
Study Contact Backup
- Name: Mauricio H Ruiz, MD
- Phone Number: 0562 - 9788409
- Email: mruiz@redclinicauchile.cl
Study Locations
-
-
Región Metropolitana
-
Santiago, Región Metropolitana, Chile
- Recruiting
- Hospital Clínico Universidad de Chile
-
Principal Investigator:
- Carlos M Romero, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Written informed consent has been obtained for the procedure
- Patients whose need of mechanical ventilation is estimated in ≥ 7 days and require a percutaneous tracheostomy
Exclusion Criteria:
- Patients younger than 18 years old
- Patients with neurologic pathology
- Patients with dysphagia history
- Patients whose MV duration is estimated in < 7 days
- Patients with airway obstruction requiring an emergency tracheostomy
- Patients already having a tracheostomy in situ
- Pregnancy
- Patients who have already been enrolled on another trial
- Patients with absolute contraindication to perform a percutaneous tracheostomy
- Patients with high risk of dying, life expectancy of < 48 hours
- Patients in whom limitation of therapy has been decided
- Family rejection to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Early percutaneous tracheostomy
|
Percutaneous tracheostomy within the first 4 days of mechanical ventilation.
Other Names:
|
Active Comparator: Prolonged translaryngeal intubation
|
Prolonged endotracheal intubation, and reevaluation at day 10 to establish the requirement of percutaneous tracheostomy.
If clinical condition determines that the patient needs a percutaneous tracheostomy, this will be performed between days 11 and 14.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of swallowing dysfunction
Time Frame: 3 to 5 days after weaning of mechanical ventilation
|
The diagnosis of swallowing dysfunction will be performed by fiberoptic endoscopic evaluation of swallowing (FEES) 3 to 5 days after weaning of mechanical ventilation.
|
3 to 5 days after weaning of mechanical ventilation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All cause mortality
Time Frame: 90 days
|
90 days
|
|
Hospital length of stay
Time Frame: 90 days
|
90 days
|
|
Ventilator-free days
Time Frame: 28 days
|
28 days
|
|
ICU-free days
Time Frame: 28 days
|
28 days
|
|
Incidence of ventilator-associated pneumonia
Time Frame: 28 days
|
28 days
|
|
Delirium-free and coma-free days
Time Frame: 28 days
|
28 days
|
|
Daily dose of sedatives
Time Frame: 28 days
|
28 days
|
|
Critical Care Unit-free days
Time Frame: 90 days
|
Length of stay at Critical Care Unit involve days of stay in thre Intensive Care Unit, plus the days of stay in the Intermediate Care Unit.
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carlos M Romero, MD, University of Chile
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Anticipated)
April 1, 2012
Study Completion (Anticipated)
June 1, 2012
Study Registration Dates
First Submitted
December 29, 2010
First Submitted That Met QC Criteria
December 29, 2010
First Posted (Estimate)
December 30, 2010
Study Record Updates
Last Update Posted (Estimate)
January 5, 2011
Last Update Submitted That Met QC Criteria
January 4, 2011
Last Verified
December 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FONIS SA10I20012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Swallowing Disorder
-
Hacettepe UniversityCompletedSwallowing DisorderTurkey
-
National Taiwan University HospitalCompletedSwallowing DisorderTaiwan
-
Showa Inan General HospitalCompleted
-
University of ManchesterCompletedDysphagia | Swallowing DisorderUnited Kingdom
-
University of ManchesterCompleted
-
Hacettepe UniversityCompletedChewing Problem | Swallowing DisorderTurkey
-
University Hospital, ToulouseFondation de l'AvenirCompletedSwallowing DisordersFrance
-
University of HaifaCompletedHealthy Aging | Gender | Swallowing Disorder
Clinical Trials on Percutaneous tracheostomy
-
Aykut SaritasProf.Dr.A.İlhan Özdemir State HospitalCompletedTracheostomy Complications
-
University of Sao PauloCompletedTracheostomy ComplicationsBrazil
-
Hadassah Medical OrganizationUnknownOther Tracheostomy Complication
-
University of GenovaUnknownHeart Failure | Acute Respiratory Failure | Neurological DiseaseItaly
-
University of AlbertaWithdrawn
-
Tel-Aviv Sourasky Medical CenterUnknownOther Tracheostomy ComplicationIsrael
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedRespiratory Failure | Cardiovascular SurgeryFrance
-
Mohamed Sayed Mohamed AbbasCompletedICU Patients Dependant on Mechanical Ventilation : Safest Mode of Performing Percutaneous Tracheostomy Among ICU Ventilated Unweanable Patients
-
Eylem YaşarCompletedTracheostomy ComplicationTurkey
-
Universitatea de Medicina si Farmacie Iuliu HatieganuRecruitingTracheostomy Complication | Tracheostomy Infection | Tracheostomy HemorrhageRomania